Insiders are Loading Up On This “Dream” Biotech Turnaround Stock (Analysts Target 45%-141% Upside)
When insiders, institutions, analysts, and catalysts all begin lining up in the same direction, the picture becomes much more compelling.
Written byGreg PatrickSource: Trades Of The Day
When insiders, institutions, analysts, and catalysts all begin lining up in the same direction, the picture becomes much more compelling.